Tussin Dm Nighttime Cough Maximum Strength

Dextromethorphan Hbr, Doxylamine Succinate


Winco Foods, Llc
Human Otc Drug
NDC 67091-333
Tussin Dm Nighttime Cough Maximum Strength also known as Dextromethorphan Hbr, Doxylamine Succinate is a human otc drug labeled by 'Winco Foods, Llc'. National Drug Code (NDC) number for Tussin Dm Nighttime Cough Maximum Strength is 67091-333. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Tussin Dm Nighttime Cough Maximum Strength drug includes Dextromethorphan Hydrobromide - 30 mg/20mL Doxylamine Succinate - 12.5 mg/20mL . The currest status of Tussin Dm Nighttime Cough Maximum Strength drug is Active.

Drug Information:

Drug NDC: 67091-333
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Tussin Dm Nighttime Cough Maximum Strength
Also known as the trade name. It is the name of the product chosen by the labeler.
Proprietary Name Base: Tussin Dm Nighttime Cough
The base of the Brand/Proprietary name excluding its suffix.
Proprietary Name Suffix: Maximum Strength
A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Dextromethorphan Hbr, Doxylamine Succinate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Winco Foods, Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:DEXTROMETHORPHAN HYDROBROMIDE - 30 mg/20mL
DOXYLAMINE SUCCINATE - 12.5 mg/20mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Feb, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 31 May, 2024
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part341
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 23 Dec, 2025
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:WinCo Foods, LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1115329
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0070552242128
UPC stands for Universal Product Code.
UNII:9D2RTI9KYH
V9BI9B5YI2
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Antihistamine [EPC]
Histamine Receptor Antagonists [MoA]
Sigma-1 Agonist [EPC]
Sigma-1 Receptor Agonists [MoA]
Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]
Uncompetitive NMDA Receptor Antagonists [MoA]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
67091-333-181 BOTTLE, PLASTIC in 1 BOX (67091-333-18) / 118 mL in 1 BOTTLE, PLASTIC01 Feb, 201931 May, 2024No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purposes cough suppressant antihistamine

Product Elements:

Tussin dm nighttime cough maximum strength dextromethorphan hbr, doxylamine succinate dextromethorphan hydrobromide dextromethorphan doxylamine succinate doxylamine anhydrous citric acid fd&c red no. 40 glycerin high fructose corn syrup menthol polyethylene glycol, unspecified propylene glycol water sodium benzoate trisodium citrate dihydrate sucralose xanthan gum fd&c blue no. 1 carboxymethylcellulose sodium

Indications and Usage:

Uses temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat controls the impulse to cough to help you sleep

Warnings:

Warnings do not use to sedate a child or to make a child sleepy if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. ask a doctor before use if you have glaucoma trouble urinating due to an enlarged prostate gland cough that occurs with too much phlegm (mucus) a breathing problem or chronic cough that lasts or as occurs with smoking, asthma, chronic bronchitis or emphysema ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. when using this product do not use more than directed marked drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery excitability may occur especia
lly in children stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. these could be signs of a serious condition. if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center (1-800-222-1222) right away.

Do Not Use:

Warnings do not use to sedate a child or to make a child sleepy if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. ask a doctor before use if you have glaucoma trouble urinating due to an enlarged prostate gland cough that occurs with too much phlegm (mucus) a breathing problem or chronic cough that lasts or as occurs with smoking, asthma, chronic bronchitis or emphysema ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. when using this product do not use more than directed marked drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery excitability may occur especially in children stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. these could be signs of a serious condition. if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center (1-800-222-1222) right away.

When Using:

When using this product do not use more than directed marked drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery excitability may occur especially in children

Dosage and Administration:

Directions this adult product is not intended for use in children under 12 years of age do not take more than 4 doses in any 24-hour period measure only with dosing cup provided. do not use any other dosing device. keep dosing cup with product ml = milliliter adults and children 12 years and over: 20 ml every 6 hours children under 12 years: do not use

Stop Use:

Stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. these could be signs of a serious condition.

Package Label Principal Display Panel:

Principal display panel *compare to the active ingredients in robitussin® maximum strength nighttime cough dm maximum strength tussin dm nighttime dextromethorphan hbr / cough suppressant doxylamine succinate / antihistamine relieves: cough, itchy throat & runny nose adult formula, for ages 12 years & over alcohol free dosage cup provided fl oz (ml) *this product is not manufactured or distributed by pfizer consumer healthcare, distributors of ronitussin® maximum strength nighttime cough dm. tamper evident: do not use if printed safety seal around bottle or under cap is broken or missing. keep outer carton for complete warnings and product information. distributed by : winco foods, llc, boise, id 83704

Package label winco foods maximum strength nighttime cough dextromethorphan hbr 30 mg,doxylamine succinate 12.5 mg

Further Questions:

Questions or comments? call 1-800-824-1706 monday-friday 9am-5pm mst


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.